Stock listing

VIRP Stock Price, News, Filings & Events — Virbac Sa

Selected listing: VIRP · BX · CHF · CH

This page tracks Virbac Sa's VIRP:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VIRP:BX. VIRP:BX is the stock-level entry point for investors researching Virbac Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Virbac Sa is a public company listed under the ticker VIRP, operating in the French market. The company has a market capitalization of approximately €3.19 billion. Virbac specializes in veterinary pharmaceuticals and is dedicated to improving animal health.

VIRP:BXCHFCHUpdated September 5, 2026

Ticker: VIRP:BX
Asset type: Stock
Market cap: $3.13B
Sector: Health Technology
Industry: Biotechnology
Exchange: BX
Currency: CHF

VIRP Stock Price, News, Filings & Events — Virbac Sa

Virbac Sa VIRP:BX stock context

Latest news from Virbac Sa

Virbac : Declaration of the number of shares and voting rights 08/2026

Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms

Virbac : Public release of Virbac Annual Report at 31 December 2025.

Leading with Care: Virbac Becomes a Human-Animal Bond Certified Company

Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms

Research Virbac Sa

Virbac Sa investor report

Virbac Sa company profile

Virbac Sa news

Virbac Sa investor events

Alternate listings

VIRP:EURONEXT

0NM7:LSIN

V16:GETTEX

VRBCF:OTC

874929:LSX

874929:LS

V16:FWB

VIRPP:TURQUOISE

VIRPP:AQUISEU

VIRPP:AQUISUK

V16:TRADEGATE

V16:DUS